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Abstract
Background Due to the lack of high-quality evidence which has hindered the development of evidence-based guidelines, there is
a need to provide general guidance on cranioplasty (CP) following traumatic brain injury (TBI), as well as identify areas of
ongoing uncertainty via a consensus-based approach.
Methods The international consensus meeting on post-traumatic CP was held during the International Conference on Recent
Advances in Neurotraumatology (ICRAN), in Naples, Italy, in June 2018. This meeting was endorsed by the Neurotrauma
Committee of the World Federation of Neurosurgical Societies (WFNS), the NIHR Global Health Research Group on
Neurotrauma, and several other neurotrauma organizations. Discussions and voting were organized around 5 pre-specified
themes: (1) indications and technique, (2) materials, (3) timing, (4) hydrocephalus, and (5) paediatric CP.
Results The participants discussed published evidence on each topic and proposed consensus statements, which were subject to
ratification using anonymous real-time voting. Statements required an agreement threshold of more than 70% for inclusion in the
final recommendations.
Conclusions This document is the first set of practical consensus-based clinical recommendations on post-traumatic CP, focusing
on timing, materials, complications, and surgical procedures. Future research directions are also presented.
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Introduction
Decompressive craniectomy (DC) is a surgical procedure fre-
quently used following traumatic brain injury (TBI) [6, 100].
Decompressive craniectomy can control intracranial pressure
(ICP) and reduce mortality with a wide range of outcome
categories in survivors, but the related complications are not
insignificant [29, 36]. While there has been a significant
amount of literature devoted to DC for TBI, the available
guidelines [6] do not include recommendations on
cranioplasty (CP), which is an operation aiming to reconstruct
the skull defect created by the DC.
As a consequence, several issues remain open to debate, in-
cluding indications, optimal surgical technique, optimal material,
timing of CP, CPwith concomitant hydrocephalus (HC), and CP
in paediatric patients [13, 18, 23, 37, 47, 69, 75, 93, 94].
When health issues are particularly complex or controversial,
and high-quality evidence to inform evidence-based guidelines is
scarce, a practical and effective solution can be a consensus-
based process. The latter is an established and formal methodo-
logical tool for reaching consensus among professionals on the
basis of the best available evidence or practice. Typically, a panel
of experts, after examining the relevant scientific information and
the clinical issues, produce clinical recommendations which re-
flect the commonly held views, in order to guide practice in
relationship to the available resources [39].
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The main objective of the international consensus meeting
on cranioplasty was to develop recommendations by using a
consensus-based approach in order to optimize the manage-
ment of TBI patients requiring CP.
Methods
Supporting agencies
The consensus meeting was held in Naples, Italy, on June 21–
22, 2018. The event was organized during the International
Conference on Recent Advance in Neurotrauma (ICRAN),
the conference of the Neurotrauma Committee (NTC) of the
World Federation of Neurosurgical Societies (WFNS).
ICRAN 2018 was held under the patronage of the Italian
Neurosurgical Society (SINch), the European Association of
Neurological Surgeons (EANS), the International
Neurotrauma Society (INTS), GLOBAL NEURO, the
Italian Society of Anaesthesia Analgesia Resuscitation and
Intensive Care (SIAARTI), the Italian Society of
Neurological Rehabilitation (SIRN), the Italian Agency for
Development Cooperation (AICS), and the National Institute
for Health Research Global Health Research Group on
Neurotrauma (NIHR GHRGN). The NTC of WFNS and the
NIHR GHRGN supported the consensus meeting.
Preparatory work
In advance of the meeting, the organizing committee devel-
oped and agreed the 5 fundamental topics that were believed
to require consideration: (1) indications and technique of CP,
(2) materials, (3) timing, (4) post-traumatic HC in patients
following DC, and (5) CP in paediatric patients.
Consensus meeting
The consensus meeting started with an open session of oral
presentations, as part of in the ICRAN 2018 programme, with
an update on the recent literature on the topics of DC follow-
ing TBI and subsequent CP.
Participating experts and working groups
The consensus meeting participants were invited with the aim
of achieving broad geographic representation. They were di-
vided into five small working groups according to the five pre-
specified topics. Each working group met in a separate room
with the aim of discussing available published evidence as
well as their personal clinical experience. Then, under the
coordination of two facilitators, each small group summarized
in a document the identified areas of agreement/disagreement,
and a preliminary list of draft recommendations for clinical
practice and areas requiring future investigation. Besides the
international panel of neurosurgical experts, Physical
Medicine and Rehabilitation (PM&R) Physicians were in-
volved as C3 participants and invited in the small groups
discussing HC and timing of CP.
Grading of approval methods
Following small group discussions, all invited delegates par-
ticipated in the next session, where the facilitators presented
the summary documents of their small group. The statements
were voted in real-time and anonymously by all invited par-
ticipants using an audience engagement software (Glisser
Limited, London, UK). The appendix (available online) in-
cludes a summary of all accepted statements and statements
that reached a poor level of consensus.
The degree of agreement was expressed with a three-point
Likert scale (agree, uncertain, and disagree). A minimum of
70% agreement for each statement was required for inclusion
in the final consensus statement. Recommendations which dur-
ing the first round of voting had levels of agreement close to 70%
(i.e. just above or just below), high levels of uncertain responses,
or similar levels of agreement and disagreement were refined
following floor discussion and put to a second round of voting.
A similar methodology has been previously adopted and report-
ed by the International Consensus Meeting on the Role of
Decompressive Craniectomy in the Management of TBI held
in Cambridge in September 2017 [35].
The decision to adopt a consensus-based methodology as
opposed to an approach such as GRADE, for example, was
based on the fact that in the field of cranioplasty the vast
majority of studies are retrospective observational. Only 2
pilot randomized trials have been published so far and the
overall level of evidence remains low.
Consensus topic 1: Indications and technique
Overview
The term post-traumatic CP refers to reconstruction of the
cranial vault following DC for TBI, which takes place at a
later stage. Craniectomies can be performed early or late, as
primary or secondary interventions [52]. As there is a general
hiatus in the literature to define the actual size and/or extent
(i.e. uni/bilateral), when post-traumatic DC is performed, the
actual size of reported CPs varies widely [75]. However, it
important to remark that either small or large cranial defects
may be related to significant neurological and psychological
consequences [21, 27]. A clear-cut definition regarding size
has been recommended by the Guidelines for the
Management of Adult Severe TBI (4th Edition) for
frontotemporoparietal DC (not less than 12 cm × 15 cm, or
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15 cm diameter) over a small frontotemporoparietal DC to
reduce mortality and improve neurologic outcomes in patients
with severe TBI [6].
Recent trials have led to an increase in the use of DC in the
acute management of severe TBI and other pathologies, even in
areas of limited surgical resources [11]. The expanding number
of DCs has been coupled with inconsistencies in operative tech-
niques. A fundamental key point to keep inmind is that sinceDC
requires a second surgery for CP, the decision making for CP
should begin at the time of the actual decompression. This would
entail surgical planning based on the original skin incision taking
into account potential scalp trauma, size, and location of the DC
tomanage the acute pathology, type, and need for dural and scalp
closure and timely identification and treatment of the acute com-
plications of the DC. All these features will ultimately define the
potential success of CP.
The broadly accepted indications for CP include the fol-
lowing: reconstruction of the cranial defect, prevention or
treatment DC-related complications including extracerebral
fluid collections, altered cerebrospinal fluid (CSF) flow, and/
or absorption resulting in HC, affected self-esteem/psycholog-
ical consequences, barotrauma-related inhibition of rehabilita-
tion, and “sinking skin flap syndrome” [46].
Voting results
1. The discussion is focused on post-traumatic cranioplasty
(CP) after DC. [Agree 97.2%]
2. The discussion covers cranial defects following bifrontal
or fronto-temporo-parietal decompressive craniectomy
(DC). [Agree 97.4%]
3. Every effort should be made to perform a CP after DC in
the absence of medical contraindications and following
consent. [Agree 100%]
4. Indications include anatomical reconstruction (CSF barrier,
bone, and soft tissue), physiological restoration, and to pro-
mote functional and psychological recovery. [Agree 100%]
5. Use of 3D planning techniques, when available, may aid
the surgical procedure. [Agree 86.5%]
6. Some fullness of the flap is not per se a contraindication to
CP. [Agree 81.6%]
7. Perioperative (temporary) CSF diversion may be consid-
ered to aid CP. [Agree 92.3%]
8. Artificial implants and bone flaps with a gap to the sur-
rounding skull should be secured. [Agree 87.2%]
Future research directions
Heterogeneity of care is particularly prevalent in TBI [61]. In
particular, inequality between various countries is reflected in
the availability of resources (e.g. 3D planning/printing,
PEEK/titanium implants). While high-end techniques are
available in a small fraction of societies, the majority of DC
takes place in low- and middle-income countries where the
incidence of TBI is the highest and DC is often used as the
primary way of treating severe TBI. Cost efficiency is a real
issue and cheaper solutions may not necessarily stand up to
long-term scrutiny. While titanium implants are more expen-
sive than autologous bone, the latter might be associated with
higher rate of infection thereby leading to a cost-benefit equi-
poise [99].
Potential future research directions, especially for resource-
limited settings, should be developed for alternative tech-
niques to avoid or reduce additional costs (e.g. bone flap stor-
age or alloplastic prosthesis) and second surgeries as widely
discussed in literature (e.g. hinge CP and variants such as four
quadrant or expansive CP) [2, 48, 80, 85].
Consensus topic 2: Materials
Overview
Despite a long-lasting debate, no agreement has been reported
in the literature regarding what is the best cranioplasty mate-
rial [86]. The majority of debates in literature concern the
optimal CP material and revolve around the choice between
autologous bone and other biomaterials, either biologic or
synthetic ones [31]. This area is wide open to further devel-
opment and refinement when it comes to CP procedures.
Autologous bone
Autologous bone has been the most commonly used material
for reconstruction CP due to the perceived higher grade of
biocompatibility and its low cost [22, 28, 47, 68].
Nevertheless, autologous bone is the only CP material associ-
ated with a specific material-related complication: bone flap
resorption (BFR) [89]. This is highly relevant in terms of
outcome due to the possible need for further surgery, with
reoperation and replacement using an alloplastic material, es-
pecially if there is structural breakdown due to BFR. The
aetiology for BFR can be variable and likely include infection,
lack of sufficient scalp and or dural blood supply, and lack of
incorporation to the surrounding bone.
Following bone removal, storage of the bone flap either in
a subcutaneous or submuscular abdominal pocket or in extra-
corporeal situations bone biobanking is required. The latter
choice in some countries is mandatory due to national rules,
and it has been thought to be the main cause of BFR.
Nevertheless, in a systematic review Corliss et al. found no
statistically significant differences in terms of infection, re-
sorption, and/or reoperation rate comparing extra-corporal
cryopreservation versus abdominal pocket storage [13].
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BFR though remains a significant concern when using au-
tologous bone. In a recent systemic review and meta-analysis
[62], an increased risk of reoperation for autologous implant
mainly related to BFR was reported, with no increased infec-
tion rates compared with synthetic material. Younger age,
shunt dependency, and bone flap fragmentation as indepen-
dent risk factors for BFR were also reported [53, 81]. A pro-
spective multi-centre study showed the development of major
complications mainly due to BFR [38].
Polymethylmethacrylate
Polymethylmethacrylate (PMMA) is a non-absorbable, radio-
lucent, inert, and very common alloplastic material for CP [22,
47]. Liquid PMMA has the advantages of being easily mold-
able and inexpensive, providing an attractive solution for
those cases in resource-poor regions. For patients who have
failedmultiple previous attempts at CP because of surgical site
infection (SSI), the liquid PMMA can be impregnated with
antibiotics and could represent an additional CP option [32].
The 3D-solid customized PMMA prosthesis [24] eliminat-
ed the disadvantage of liquid PMMA, such as the exothermic
reaction during polymerization, the surgeon dependency of
the intra-operative preparation, the relative contraindication
in pregnancy, and the fact that toxic fumes are released.
Titanium
Titanium CP can be utilized for CP as a plate, mesh, or 3D
porous implant. Hardness and stability are the main advan-
tages of this material [33]. Titanium plates constitute the most
common solution, with better cosmetic and functional out-
comes, compared to autologous bone without increasing over-
all health care costs as reported in a recent randomized con-
trolled trial [31]. However, non-physiological heat conduc-
tion, radiopacity with significant artefact, and difficulty
intra-operatively shaping are the main disadvantages.
Titanium meshes are more heterogeneous in terms of thick-
ness, stiffness, and degree of conformability. They can be
manually shaped, taking into account that the wider the defect,
the less hard and more malleable is the mesh. Preoperative
radiotherapy and free flap coverage were associated with com-
plications, and an increased incidence of soft tissue atrophy
was associated with the use of titanium mesh in a large series
of 50 patients, although the titanium mesh was generally well
tolerated [10].
Most recently 3D porous titanium has been suggested as a
reliable alternative [19]. Despite its high cost and limited lit-
erature available, 3D porous titanium shows promising results
about the achievement of most complex skull reconstructions
with a shorter operative time.
Polyetheretherketone
Polyetheretherketone (PEEK) is a more recent material that is
also presently utilized for CP. It is also an inert, durable, and
mechanically sound material, but at the time of this consensus
conference, there were no studies on its long-term efficacy and
complication rate. A trend toward decreased post-operative
complication rates as compared to autologous grafts has been
reported in a systematic review and meta-analysis [77].
Additionally, the rate of overall complications including
post-operative new-onset seizures, postoperative implant ex-
posure, and reoperation after CP was reportedly lower in a
PEEK CP group than in those patients treated with titanium
CP [102]. Required in-house sterilization and a possibility of
increased seroma formation due to the smooth surface could
represent the main disadvantage of this material.
Porous hydroxyapatite
Hydroxyapatite (HA), makes up the main component of the
substitute bone implant. Approximately 50% of the dry weight
of bone matrix is inorganic materials, the most abundant of
which is HA [41]. An advantage of HA is its biocompatibility
due to the absence of host immune interactions or systemic/local
toxicity [9]. Osteoconductivity and biocompatibility of porous
HA implants have been confirmed in multiple studies [72].
Fracture of the prosthesis in the first months after implant due
to its porous structure is the main reported disadvantage of this
material. Nevertheless, the specific property of porous structure
provides the possibility of self-repair following head trauma and
fracture [87]. A postoperative analysis of complications in 1549
patients showed a fracture incidence of 2.1%, and a re-operation
incidence for fracture of 0.9% [88]. Among fractured prostheses,
there was a re-operation incidence of 44.4% as well as a self-
repaired occurrence of 18.1% observed. A pilot randomized trial
of HA vs titanium found that the rate of local implant-associated
wound infection in theHAgroupwas 2 of 26 (7.7%) patients and
5 of 24 (20.8%) patients in the titanium group (p = 0.407). In
both groups, 7 patients required reoperation at the 6-month fol-
low-up (26.9% of the HA group and 29.2% of the titanium
group). Due to the limited sample size, these results need to be
interpreted with caution [60].
Complications related to materials for CP following
post-trauma DC
Complications following CP can result from the intervention
itself, or as a result of factors apparently unrelated to the CP
procedure. Thus, separating complications related to CP from
those deriving from the clinical history of the patient from the
initial bone removal remains a challenge, and, as evidenced by
our discussions, at present there is no clear superiority of one
material over others.
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Predictors of CP complications are as follows: previous
reoperation, comorbidities such as unhealthy bodymass index
(BMI), smoking, diabetes in the case of stroke patients as well
the presence of a ventriculoperitoneal shunt (VPS), as reported
by Walcott et al. [96]. Skin flap complications following DC
and CP have also been reported [18], but still no relationship
has been reported among the different biomaterials used for
the CP and type and extent of complications.
The location of the DC appears related to CP complications.
Analyses of series using varying biomaterials found that bifrontal
CP was associated with a 2-fold increased risk of complication
and a 2.5-fold increased risk of developing infection compared
with hemispheric/bihemispheric CP [16], using different CP ma-
terials. A retrospective review of autologous CP reported that
67%of 12 bifrontal compared to 16%of 49 unilateral autologous
CP required reoperation (p < 0.01) [23].
In a large series of 98 PMMA CP and minimum 2-year fol-
low-up, there were 9 removed implants, 8 as a result of infection
due to direct frontal sinus involvement [9]. The largest incidence
of infection was in patients with a bifrontal defect (3.8%) in an
analysis of 1549 patients with HA implants [88]. A large retro-
spective UK study on 174 titanium CP to date [69] showed that
bifrontal insertion is one of the most relevant risk factors for
complications with a complication rate of 40%.
Bone or alloplastic implant removal until complete healing
of the surgical field has occurred is the usual management of
an infected CP. In a close future, a project to develop materials
capable of resisting colonization and more effective pharma-
cological treatment against infections will be necessary.
In a recent study of four cases of infectious complications,
it has been suggested that porous HA CP may be utilized for
improved prosthesis retention management [37] due to a low-
er biofilm colonization rate and increased revascularization. It
was suggested that the revascularization resulted in improved
“in situ” intake of antibiotics due to the porous structure, and
in combination with targeted antibiotic therapy, may prevent
the need for prosthesis removal.
This concept might lead to some promising future applica-
tions using porous surface material such as HA and 3D porous
titanium CPs.
Voting results
1. The question of the optimal material for cranioplasty (i.e.
bone graft, synthetic) with regard to clinical outcome,
cosmesis, and complications remains unanswered.
[Agree 88.5%]
2. Bone graft carries the risk of resorption. [Agree 100%]
3. The influence of storage methods on resorption rates is
unclear. [Agree 88.5%]
4. Progressive resorption over time can affect bone stored
subcutaneously, so early cranioplasty can be considered.
[Agree 96%]
5. The influence of timing of cranioplasty on resorption rates
of bone graft remains unclear. [Agree 88.5%]
6. Custom-made implants may have better cosmetic out-
comes and this should be studied further. [Agree 92%]
Future research directions
The application of nanotechnologies to HA/polymer compos-
ite will undoubtedly be key to optimizing HA as a biocompat-
ible material of choice [25]. Even if porous titanium by itself is
inert and shows poor surface activity without surface
biomodification, some bone in-growth rate (BIR) is still ob-
served without surface biomodification. However, a substan-
tial BIR is seen when HA is Si-HA coated, the SI-HA-coated
porous titanium showing the highest BIR [101]. Almost all
materials are now being deployed to produce 3D CP patient
specific implants (PSI). It has been suggested that this will
improve cosmetic benefit, but it has not yet been proven to
have a positive impact on outcome. 3D-printing and
stereolithography application in neurosurgery [3] could have
a growing use, such as to create moulds to be filled with liquid
PMMA [7, 58], to obtain an intraoperative symmetric CP not
limited by the manual skill of the surgeon. Titanium meshes
may be stereo-lithographically created using direct metal laser
sintering in order to create a structural foundation [10, 65],
while custom-made porous titanium graft can be shaped with
electron beam melting technology [19].
In the near future, the largest barriers to artificial implants
such as the costs, low confidence as to improved outcomes by
clinicians, and government and health insurance for printing
[74] will hopefully be reduced with increased widespread
adoption of this technology.
Further evidence will be required with regard to the optimal
material for cranial reconstruction.
Consensus topic 3: Timing
Overview
Literature meta-analysis, reported retrospective cohorts, and
prospective studies did not define a clear correlation among
time interval between bone removal and CP and any resultant
major complications and outcome [14, 16, 55, 68, 76]. In the
literature, the definition of “early CP” is ill-defined and has
been reported at various time intervals varying from less than
4 weeks up to 12 weeks. Because of this lack of consistency in
the literature, the impact of timing on functional outcome is
not well defined from literature data [22, 31, 47, 86].
However, a recent comprehensive systematic review conclud-
ed that CP may “improve neurological function, and earlier
cranioplasty may enhance this effect” [63].
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A lower rate of complications [8, 78, 79, 82, 98] associated to
early CP has been described. However, some authors [83, 91]
have found that early CP is associated with more complications,
in particular the higher rate of infection between 0 and 6 months.
A correlation between good outcome and benefits from CP
such as improved postural blood flow, cerebrovascular reserve
capacity, and cerebral glucose metabolism is far from having
been established but has been preliminarily suggested. It is
therefore just logical to consider that the earlier the CP, the
sooner it is performed; there may be additional benefits to
recovery by this yet to be proven [40, 59].
The ideal timing among several studies would seem to sug-
gest that the time-window is probably not the same for each
patient, and may be related to the individual patient’s clinical
condition including the presence of haemodynamic or respiratory
instability, infection status, a clinical diagnosis of minimally con-
scious or vegetative states [20, 34, 92], delayed wound healing
from the initial surgeries or other trauma-related surgeries (i.e.)
abdominal, chest, orthopaedics, etc., ongoing bleeding diathesis,
or any condition related to the trauma itself such as the brain
condition at the moment of proposed CP.
The timing of CP should also take into account the state of
the skin flap: (i) depressed skin flap, due to post-traumatic
brain atrophy or over-drainage of CSF related to VP shunting;
(ii) skin flap is at the same level as the margins of the cranial
vault; (iii) skin flap is bulging beyond the cranial vault margin
due to brain swelling and/or HC/ventriculomegaly (VM).
Voting results
1. Cranioplasty may improve neurological function, and
earlier cranioplasty may enhance this effect. [Agree
84.6%]
2. Defining a threshold for early vs late cranioplasty is ar-
tificial but can be useful for clinical benchmarking and
research purposes. Taking into account the previous
statement, ultra-early cranioplasty is up to 6 weeks fol-
lowing craniectomy, early cranioplasty is 6 weeks to 3
months, intermediate 3–6 months, and delayed more
than 6 months. [Agree 86.8%]
3. The clinical condition of the patient (e.g. wound status,
systemic infection, systemic instability, antithrombotic
medications) should be taken into consideration when
deciding the timing of cranioplasty. [Agree 100%]
4. Poor neurological status is not a contraindication for
cranioplasty per se. [Agree 92.1%]
5. Consider expediting the cranioplasty in a patient with
neurological and/or neuropsychological deterioration
that cannot be attributed to extracranial causes. [Agree
81.6%]
6. The odds of infections, reoperations, intracranial haem-
orrhage, and seizures do not appear different between
early and late cranioplasty. [Agree 88%]
7. Progressive resorption over time can affect bone stored
subcutaneously, so early cranioplasty can be considered.
[Agree 96%]
8. Skin colonization (i.e. carrier) of the patient is not a
contraindication for cranioplasty but consideration to de-
colonization pre-operatively should be given. [Agree
92%]
9. The effect of timing on neurological outcome should be
explored in future, prospective studies. [Agree 89.7%]
10. The relationship between the timing of CP and HC needs
to be explored in future studies. [Agree 89.5%]
11. The development of specific outcome measures follow-
ing cranioplasty should be considered. [Agree 94.7%]
Future research directions
At present, there is an ongoing prospective, multi-centre, ob-
servational study on outcomes CP (UK Cranioplasty Study)
that may be able to shed some light on the issue of timing [50].
Future studies evaluating the relationship between the
timing of CP on neurological outcome and or the development
of HC are necessary, especially randomized trials.
Consensus topic 4: Hydrocephalus
Overview
The development of ventriculomegaly (VM) after DC for se-
vere TBI is well documented. Its incidence significantly varies
among the reported series from 40 to 45% [30, 64]. However,
among the patients that develop VM following TBI, only a
small percentage require the insertion of a ventriculo-
peritoneal (or less frequently lumbar-peritoneal) shunt for its
management [30, 64, 95]. This discrepancy requires to differ-
entiate the features of clinically proven hydrocephalus (HC),
which requires surgical treatment, to those of VM, which re-
fers to ex vacuo dilatation of the ventricular system resulting
from brain atrophy due to severe TBI.
Even after differentiating HC from VM, the actual inci-
dence of HC among patients underwent DC for TBI varies
significantly among the published series (10–45%) [30, 43,
70, 95]. The vast majority of the published series are retro-
spective studies, carrying all the weaknesses and the potential
biases related to their retrospective nature. There are only two
retrospective studies with prospectively collected data in the
pertinent literature [93, 95]. Moreover, the number of different
criteria for diagnosis of VM or HC following post-traumatic
DC may represent another factor to explain the wide range in
the rate of incidence of HC [12, 17, 30, 90].
Several predisposing factors for the development of HC
following posttraumatic DC are summarized in Table 1.
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Several reported series have demonstrated an association be-
tween post-DC HC and factors including the development of an
interhemispheric hygroma [17, 42, 70, 95], or subdural hygroma
[30], severity of the initial injury as reflected by a low admission
GCS score and the increased ICP during the acute course [1, 42].
Higher risk of developing post-DC HC for younger patients [70,
95], and for bifrontal DC in comparison to unilateral DC has
been reported, although not statistically significant [30]. A statis-
tically significant association between distance of the DC border
less than 2.5 cm to the anatomical midline and the development
of HC has been reported [17].
The time interval between theDC and the development ofHC
varies between the reported series, with a median time interval of
6.4 months (range 1–15) or 43.7 days (range 23.5–199), but it
seems that HC takes at least 1 month to develop after DC [70,
95]. Interestingly, the previously published series agreed on the
finding that the vast majority of patients (> 80%)who develop an
interhemispheric hygroma after a DCwill develop HCwithin 50
days from the DC [17, 42, 70, 95].
The development of specific diagnostic criteria for HC in
the context of post-decompression VM should be further stud-
ied. The establishment of the diagnosis of post-DC HC re-
quires both the presence of clinical symptoms and signs, along
with radiologically proven VM [70].
However, it is unlikely that the post-DC HCwill present with
the typical clinical triad observed for the idiopathic normal pres-
sure hydrocephalus (cognitive deterioration, gait abnormalities,
and urinary incontinence), as the underlying TBI is likely to have
caused severe neurological impairments that submerge this typ-
ical symptomatology [97]. Thus, HC should be suspected, in the
presence ofVM,when patients fail to have the expected recovery
following the initial event (exceedingly slow or arrested recov-
ery) or when preexisting cognitive and/or motor deficits begin to
deteriorate (progressive neurological deterioration) or even in
case of atypical symptoms of new onset such as seizures [15].
The onset of the aspecific HC symptomatology often takes
place during the post-acute phase, where patients with DC are
often admitted to specialized intensive rehabilitation, in view of
the complex disabilities following TBI [45, 54, 66]. As the clin-
ical presentation of HC is often subtle, there is a need to docu-
ment the arrested recovery or the progressive neurological
deterioration caused by HC using clinical scales. These scales
should be able to assess the patient’s functional status over time
and that are enough responsive to the subtle and mild changes of
the patient’s neurological condition. For instance, the Coma
Recovery Scale-Revised (CRS-R) is definitely appropriate to
detect even subtle neurological changes in patients with post-
traumatic DC affected by a disorder of consciousness (DOC)
[84]. However, the same scale is not appropriate for patients
who have emerged from DOC being in a post-traumatic confu-
sional state. Indeed, clinical scales which are targeted to the func-
tional level of the patients should be used. In this respect, an
outcome scale such as the Glasgow Outcome Scale, even in its
extended form, is unlikely to be enough sensitive to change to
capture these subtle changes and, thus, its use cannot be recom-
mended. For these reasons, the operationalization of the diagnos-
tic criteria for HC in the context of post-decompression VM
should be further studied.
However, early recognition of post-DCHC is of paramount
importance, since its proper management can improve the
patient’s neurological status and her/his overall outcome [54].
All previous reports and reviews agreed on the fact that
the development of post-DC HC is associated with worse
outcome [17, 30, 42, 70]. Previous series have shown that
delayed restorative CP (more than 3 months after the DC)
is associated with HC [70]. However, other series con-
cluded that timing of CP was not associated with the
development of HC [1, 30, 42]. A more recent systematic
review concluded that CP within 90 days after DC in TBI
patients alone was associated with a lower incidence of
hydrocephalus [71].
The disappearance of VM after CP is well documented.
Thus, the existing controversies about the proper management
for HC and CP regard the timing of CSF diversion with re-
spect to the cranial reconstruction. When a CSF shunt is re-
quired, no evidence exists in the literature regarding the best
time option (before, synchronously, or after CP) for insertion
[44, 51, 56, 57, 60, 70, 73, 93].
A CP before the VPS may prolong and intensify the effect
of HC to the brain [98], but at the same time may increase the
technical difficulty of a subsequent CP [59]. In a previously
published study, a higher incidence of anaesthesia-related and
prophylactic antibiotic–related complications is reported [40].
A CP performed after VPS has been reported to be associated
with higher complication rate, and an increased shunt revision
rate [59]. In cases of simultaneous performance of VPS and
CP, higher perioperative complications, including higher in-
fection rates, have been reported [26, 40], although other re-
ports found the incidence to be similar [67].
Based on a number of case series, it has been suggested that
programmable shunts could be effective in the management of
HC following post-traumatic DC. Nevertheless, a fixed
pressure-valve is a well-recognized treatment in socio-






Low GCS score upon admission*
Increased ICP before DC
Elderly patients
Proximity of the DC (< 2.5 cm) to the
anatomical midline
Delayed (> 3 months) CP
*According to classification of TBI sever-
ity based on GCS
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especially significant given the availability of a number of
lower-cost fixed-pressure shunts that may be more useful in
the setting of lower resources [40, 59].
Voting results
1. With regard to the best imaging method for following
patients with VM, there is not adequate evidence in the
literature. [Agree 81.6%]
2. The performance of serial cranial imaging (e.g. CT, MRI)
can provide information regarding any changes in the pa-
tient’s ventricular system. [Agree 81.6%]
3. With regard to the best electrophysiological test for fol-
lowing patients with ventriculomegaly, there is not ade-
quate evidence in the literature identifying such a modal-
ity. [Agree 92.1%]
4. The optimal management of decompressed patients with
ventriculomegaly remains uncertain, but the performance
of a cranioplasty prior to definitive CSF diversion should
be considered as it can help restore an intact intracranial
system. [Agree 95.8%]
5. In those patients that there is a bulging skin flap, the usage
of a temporary external ventricular drain (EVD) or a lum-
bar drain (LD) may facilitate the cranioplasty. The perfor-
mance of serial spinal taps, although is not supported by
enough evidence, is an option to facilitate the
cranioplasty. [Agree 94.7%]
6. After the performance of cranioplasty, the patient should
be closely followed for signs of HC. In case of persisting
or developing HC, CSF diversion needs to be considered.
[Agree 92.1%]
7. The development of specific diagnostic criteria and out-
come measures for post-traumatic HC should be a high
priority. [Agree 84%]
8. The development of specific diagnostic criteria for HC in
the context of post-decompression VM should be studied
further. [Agree 100%]
9. CSF infusion studies may be helpful in patients with VM
to determine the presence of HC, after a cranioplasty has
been performed. [Agree 95%]
Future research directions
Clinical studies of high methodological quality evaluat-
ing the relationship between CSF disorders after DC
and the impact of CP are required. Studies looking for
the development of specific diagnostic criteria and out-
come measures for post-traumatic HC should be a high
priority in order to use these criteria in subsequent
research.
Consensus topic 5: Paediatric
Overview
TBI is the most common cause of death and disability in
children. The most recent edition of the paediatric guidelines
for the management of severe TBI has recommended the use
of DC in order to reduce intracranial hypertension as a second
tier therapy [43, 49].
Following resolution of the acute period of the secondary
injury phase associated with intracranial hypertension, there
needs to be consideration for reconstruction of the surgical
defect [4]. Post-traumatic CP as noted above is a routine neu-
rosurgical procedure to restore CSF dynamics and cosmesis,
and to provide cerebral protection, all which can facilitate
improved neurologic rehabilitation as well as an improved
neurologic outcome, particularly in the paediatric population.
As paediatric post-traumatic CP is not as common an oc-
currence as in the adult, it is necessary to provide general
guidance for all controversies as well as the role of specialty
paediatric centers for definitive care. The literature to date has
not helped to define a clear optimal strategy; specifically [5,
20] , there has been no consensus reported about the type of
surgical approach for the dissection/reconstruction of the de-
fect, the type of materials, and the optimal timing when the CP
procedure should be performed.
Voting results
Defining the parameters and indication of paediatric
post-traumatic paediatric ICP
1. The paediatric population for the purposes of this consen-
sus statement is defined as children less than 18 years of
age. [Agree 78.9%]
2. All statements could be applied to bifrontal and fronto-
temporo-parietal cranioplasties. [Agree 94.7%]
3. The assumption is that the decompressive craniectomies
for children especially young children were proportional
to size of the child. The cranioplasty/reconstruction would
be proportional to the size of the defect. [Agree 100%]
4. Following DC, there should be no age limit for recon-
struction. [Agree 92.1%]
Materials in a post-traumatic paediatric CP
1. After DC, autologous bone is preferred for all ages of
children. [Agree 78.4%]
2. If autologous bone is not available, an osteoconductive ma-
terial should be preferred for reconstruction. [Agree 84.2%]
3. Below 3 years of age, the best option for osteoconductive
material remains unclear. [Agree 84.2%]
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4. If a child is more than 3 years of age, and an
osteoconductive material is not available, a synthetic ma-
terial can be used but the best option for synthetic mate-
rial remains unclear. [Agree 89.5%].
Timing of post-traumatic paediatric CP
1. Systemic, neurologic, and wound conditions must be sta-
ble prior to consider cranioplasty. [Agree 81.6%]
2. There is uncertainty about the optimal timing for CP in
paediatric population. [Agree 81.6%]
3. Recent neuroimaging is suggested prior to CP but
there is uncertainty about the optimal neuroimaging
modality (e.g. CT, MRI, ultrasound). [Agree 78.4%]
Future research directions
Since there is limited literature in the area of paediatric CP,
it was felt that there were a number of issues that could be
addressed through future research. These include the sur-
gical technique both for DC and the follow-up reconstruc-
tive CP, especially in children less than 1 year of age. Since
the consensus was that the optimal materials for paediatric
CP remains unclear, comparisons between autograft, allo-
graft, osteoconductive materials, and synthetic materials
would be useful in paediatric patients to determine whether
there is indeed any difference in overall outcome, bony
ingrowth, and complications both short-term and long-
term.
It was also considered whether cadaveric allografts may be
more beneficial in children because of their higher likelihood
for bone incorporation though this too would require further
research. Lastly since the optimal timing for CP in children
remains unclear, a useful study could include the evaluation of
outcome after the primary CP, comparing the different timing
in reconstructive cases, those cases that have been complicat-
ed by severe cranial site infection requiring removal of the
implant, and the best material for a secondary CP after these
types of situations.
Conclusion
This paper reports the final results of the first interna-
tional consensus meeting on post-traumatic cranioplasty
with the specific aim of developing recommendations
based on literature reviews and experts’ opinions in order
to facilitate the management of patients requiring CP
globally.
Overall, 45 consensus statements were voted and
agreed upon. Despite CP becoming a regularly common
surgical procedure for patients undergoing DC following
TBI, there are important gaps in the actual literature to
define evidence-based recommendations for guiding clin-
ical practice in different regions of the world. Hence, the
objective of this process was to develop recommendations
based on expert opinion in order to support decision mak-
ing for day-to-day practice.
High-quality, methodologically robust, research is ur-
gently required in many aspects of this procedure, such
as alternative techniques of bone removal/cranial recon-
struction, ideal material of cranioplasty, relationship be-
tween the timing of CP on neurological outcome, and or
the development of HC with specific diagnostic criteria
and outcome measures, in order to develop evidence-
based recommendations and subsequent resource-
stratified algorithms.
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Appendix
Table 2 Summary of all the statements voted during the consensus conference
Indications and technique
• The discussion is focused on post-traumatic cranioplasty (CP) after DC.
• The discussion covers cranial defects following bifrontal or fronto-temporo-parietal decompressive craniectomy (DC).
• Every effort should be made to perform a CP after DC in the absence of medical contraindications and following consent.
• Indications include anatomical reconstruction (CSF barrier, bone, and soft tissue), physiological restoration, and to promote functional and
psychological recovery.
• Use of 3D planning techniques, when available, may aid the surgical procedure.
• Some fullness of the flap is not per se a contraindication to CP.
• Perioperative (temporary) CSF diversion may be considered to aid CP.
• Artificial implants and bone flaps with a gap to the surrounding skull should be secured.
Materials
• The question of the optimal material for cranioplasty (i.e. bone graft, synthetic etc) with regard to clinical outcome, cosmesis, and complications
remains unanswered.
• Bone graft carries the risk of resorption.
• The influence of storage methods on resorption rates is unclear.
• Progressive resorption over time can affect bone stored subcutaneously, so early cranioplasty can be considered.
• The influence of timing of cranioplasty on resorption rates of bone graft remains unclear.
• Custom-made implants may have better cosmetic outcomes and this should be studied further.
Timing
•Cranioplasty may improve neurological function, and earlier cranioplasty may enhance this effect.
•Defining a threshold for early vs late cranioplasty is artificial but can be useful for clinical benchmarking and research purposes. Taking into account the
previous statement, ultra-early cranioplasty is up to 6 weeks following craniectomy, early cranioplasty is 6 weeks to 3 months, intermediate 3-6
months, and delayed more than 6 months.
• The clinical condition of the patient (e.g. wound status, systemic infection, systemic instability, antithrombotic medications) should be taken into
consideration when deciding the timing of cranioplasty.
• Poor neurological status is not a contraindication for cranioplasty per se.
• Consider expediting the cranioplasty in a patient with neurological and/or neuropsychological deterioration that cannot be attributed to extracranial
causes.
• The odds of infections, reoperations, intracranial haemorrhage, and seizures do not appear different between early and late cranioplasty.
• Progressive resorption over time can affect bone stored subcutaneously, so early cranioplasty can be considered.
• Skin colonization (i.e. carrier) of the patient is not a contraindication for cranioplasty but consideration to decolonization pre-operatively should be
given. [Agree92%]
• The effect of timing on neurological outcome should be explored in future, prospective studies.
• The relationship between the timing of CP and HC needs to be explored in future studies.
• The development of specific outcome measures following cranioplasty should be considered.
Hydrocephalus
•With regard to the best imaging method for following patients with VM, there is not adequate evidence in the literature.
• The performance of serial cranial imaging (e.g. CT, MRI) can provide information regarding any changes in the patient’s ventricular system.
•With regard to the best electrophysiological test for following patients with ventriculomegaly, there is not adequate evidence in the literature identifying
such a modality.
• The optimal management of decompressed patients with ventriculomegaly remains uncertain but the performance of a cranioplasty prior to definitive
CSF diversion should be considered as it can help restore an intact intracranial system.
• In those patients that there is a bulging skin flap, the usage of a temporary external ventricular drain (EVD), or a lumbar drain (LD) may facilitate the
cranioplasty. The performance of serial spinal taps, although is not supported by enough evidence, is an option to facilitate the cranioplasty.
• After the performance of cranioplasty, the patient should be closely followed for signs of HC. In case of persisting or developing HC, CSF diversion
needs to be considered.
• The development of specific diagnostic criteria and outcome measures for post-traumatic HC should be a high priority.
• The development of specific diagnostic criteria for HC in the context of post-decompression VM should be studied further.
• CSF infusion studies may be helpful in patients with VM to determine the presence of HC, after a cranioplasty has been performed.
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